Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Gilead Sciences Inc.
GILD
Healthcare
Drug Manufacturers - Major
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on...
HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition and pending Forty-Seven acquisition boost Gilead's exposure to cell therapy and noncell therapy in oncology.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:GILD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(0)
•••
Peng26
X
Post by
Peng26
on Apr 13, 2023 5:19am
Kevin Harrington Speaks about FSD Pharma
FSD Pharma Inc is about to launch this breakthrough product!!
(1)
•••
Rebecca
X
Post by
Rebecca
on Apr 13, 2023 3:13am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(3)
•••
jonathanS
X
Post by
jonathanS
on Aug 03, 2022 9:15am
roughly $80 billion biopharmaceutical company
The wide array of offerings helps fuel consistent payouts to shareholders. Current distributions are 73 cents per quarter, up 70% from 43 cents a share back at the beginning of 2016 and proof that
...more
(1)
•••
Rebecca
X
Post by
Rebecca
on Jul 15, 2022 8:49pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(1)
•••
Rebecca
X
Post by
Rebecca
on Jun 03, 2022 4:19am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
(1)
•••
Rebecca
X
Post by
Rebecca
on Jun 01, 2022 11:54pm
FSD Pharma Files Investigational New Drug Application “IND”
(1)
•••
Rebecca
X
Post by
Rebecca
on May 10, 2022 11:55pm
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(1)
•••
Rebecca
X
Post by
Rebecca
on May 03, 2022 9:45pm
Lucid-MS for Multiple Sclerosis Treatment
(1)
•••
Rebecca
X
Post by
Rebecca
on Apr 26, 2022 1:18am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(1)
•••
Rebecca
X
Post by
Rebecca
on Apr 19, 2022 1:05am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(4)
•••
zeropointenergy
X
Post by
zeropointenergy
on Oct 09, 2021 6:41am
IVERMICTIN KILLS COVID 19 !
NICE China Reports Zero New Locally Acquired Covid-19 Cases for Fourth Day in a Row
(4)
•••
zeropointenergy
X
Post by
zeropointenergy
on Oct 06, 2021 7:39am
ONE DRUG PILL WIPES OUT COVID 19!
India's Ivermectin Blackout - Part V: The Secret Revealed ... Sep 27, 2021 · By September 12, 2021, Livemint reported that 34 districts were declared COVID-free
...more
(39)
•••
omylord
X
Post by
omylord
on Jun 09, 2021 4:04pm
TRODELUY
This new drug , vaccine ive been reading about may help my wife , stage 2 triple negative breast cancer . anyone have any contacts , maybe hope .
(0)
•••
Saaaa1
X
Post by
Saaaa1
on May 06, 2021 9:00pm
$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀
iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver, British Columbia - (Newsfile Corp. - April 20, 2021) - iMining
...more
(13)
•••
Jilly17
X
Comment by
Jilly17
on Apr 13, 2021 6:31pm
RE:Sky’s the limit
I bought in many,v many moons ago. Looks like it might finally pay off!
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
Featured News Links
Green Metals Royalty Company: "The Perfect Junior Mining Investment?" - Read More Here
Milestone Agreement for Developing Radiology Drugs Announced
Exclusive Insights on the Precious Metals Industry and What to Expect in 2023 – Download free report